+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Genomic Collaboration and Licensing Deals 2018-2025 - Product Thumbnail Image

Genomic Collaboration and Licensing Deals 2018-2025

  • Report
  • November 2025
  • 550 Pages
  • Global
From
Viral Vector Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Viral Vector Collaboration and Licensing Deals 2016-2025

  • Report
  • November 2025
  • 250 Pages
  • Global
From
Thrombosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Thrombosis Drugs - Global Strategic Business Report

  • Report
  • March 2026
  • 387 Pages
  • Global
From
From
From
From
Gastrointestinal Diseases Therapeutics Market 2025-2029 - Product Thumbnail Image

Gastrointestinal Diseases Therapeutics Market 2025-2029

  • Report
  • June 2025
  • 215 Pages
  • Global
From
Biosimilars World Market - Product Thumbnail Image

Biosimilars World Market

  • Report
  • January 2023
  • 28 Pages
  • Global
From
From
From
Autoimmune Drugs - Global Strategic Business Report - Product Thumbnail Image

Autoimmune Drugs - Global Strategic Business Report

  • Report
  • March 2026
  • 287 Pages
  • Global
From
Anti-Inflammatory Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Inflammatory Drugs - Global Strategic Business Report

  • Report
  • March 2026
  • 488 Pages
  • Global
From
Interferon - Global Strategic Business Report - Product Thumbnail Image

Interferon - Global Strategic Business Report

  • Report
  • March 2026
  • 153 Pages
  • Global
From
Pharmerging - Global Strategic Business Report - Product Thumbnail Image

Pharmerging - Global Strategic Business Report

  • Report
  • March 2026
  • 184 Pages
  • Global
From
Critical Care Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Critical Care Therapeutics - Global Strategic Business Report

  • Report
  • March 2026
  • 280 Pages
  • Global
From
Loading Indicator